跳至主要内容
临床试验/NL-OMON54464
NL-OMON54464招募中不适用

Role of host cell DNA methylation analysis in predicting non-regression or regression of high-grade anal intraepithelial neoplasia in HIV+ men trial (MARINE) - MARINE

Academisch Medisch Centrum0 个研究点目标入组 240 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Study group (N=200) - HIV+ patients of at least 18 years of age that are
  • cisgender men, transgender men or transgender women and who have sex with men
  • (further referred to as HIV+ MSM); - histopathological confirmed HGAIN (>=1
  • lesion); - satisfactory HRA at baseline, i.e. visualisation of entire
  • transformation zone with biopsies of all lesions; Substudy HIV-positive group
  • (N=20): - >18 years of age - Compliance to ART, undetectable viral load since
  • at least 1 year - A low nadir CD4 cell count (<200 cell/µl) -
  • Histopathologically confirmed HGAIN (>=1 lesion); - Satisfactory HRA at
  • baseline, i.e. visualisation of entire transformation zone with biopsies of all
  • lesions; Substudy HIV-negative group (N=20) - >18 years of age -
  • Histopathologically confirmed HGAIN (>=1 lesion); - Satisfactory HRA at
  • baseline, i.e. visualisation of entire transformation zone with biopsies of all

排除标准

  • Study group: - HGAIN covering more than 50% of the circumference of the anal
  • canal (progression to cancer of these patients is estimated as high and
  • therefore withholding treatment would be unethical); - clinical suspicion for
  • anal cancer, defined as palpable abnormalities at DARE and suspicion of
  • invasion at MRI; - histopathological diagnosis of anal cancer; - history of
  • anal cancer; - previous HPV vaccination (including participants of the
  • VACCAIN-T and VACCAIN-P trial); - concomitant cancer; - insufficient Dutch or
  • English language skills. Substudy group (N=40): - Clinical suspicion for anal
  • cancer, defined as palpable abnormalities at DARE and suspicion of invasion at
  • MRI; - Histopathological diagnosis of anal cancer; - History of anal cancer; -
  • Previous HPV vaccination (including participants of the VACCAIN-T and VACCAIN-P
  • trial); - Known active chronic infection such as hepatitis B or C - Diabetes
  • mellitus - Insufficient Dutch or English language skills. - Presence of any
  • diseases affecting the anal mucosa (fistulas, rhagades, eczema). - Signs of
  • current STI.

研究者

相似试验